Mifepristone's Adverse Event Reporting: Cause for Concern at FDA

The FDA's handling of safety data for mifepristone highlights the need for comprehensive adverse event collection to protect women's health.

Related Keywords

United States ,America , ,Drug Administration ,Risk Evaluation ,Mitigation Strategy ,Aside Abortion Politics ,Medication Guide ,Assure Safe Use ,